Saundra L Pelletier - Net Worth and Insider Trading

Saundra L Pelletier Net Worth

The estimated net worth of Saundra L Pelletier is at least $4,685 dollars as of 2024-05-25. Saundra L Pelletier is the CEO of Evofem Biosciences Inc and owns about 236,722 shares of Evofem Biosciences Inc (EVFM) stock worth over $3,788. Saundra L Pelletier is also the Director of TRACON Pharmaceuticals Inc and owns about 602 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $897. Details can be seen in Saundra L Pelletier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Saundra L Pelletier has not made any transactions after 2022-05-27 and currently still holds the listed stock(s).

Transaction Summary of Saundra L Pelletier

To

Saundra L Pelletier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Saundra L Pelletier owns 2 companies in total, including Evofem Biosciences Inc (EVFM) , and TRACON Pharmaceuticals Inc (TCON) .

Click here to see the complete history of Saundra L Pelletier’s form 4 insider trades.

Insider Ownership Summary of Saundra L Pelletier

Ticker Comapny Transaction Date Type of Owner
EVFM Evofem Biosciences Inc 2022-05-27 director & Chief Executive Officer
TCON TRACON Pharmaceuticals Inc 2021-07-26 director

Saundra L Pelletier Latest Holdings Summary

Saundra L Pelletier currently owns a total of 2 stocks. Among these stocks, Saundra L Pelletier owns 236,722 shares of Evofem Biosciences Inc (EVFM) as of May 27, 2022, with a value of $3,788 and a weighting of 80.85%. Saundra L Pelletier also owns 602 shares of TRACON Pharmaceuticals Inc (TCON) as of July 26, 2021, with a value of $897 and a weighting of 19.15%.

Latest Holdings of Saundra L Pelletier

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EVFM Evofem Biosciences Inc 2022-05-27 236,722 0.02 3,788
TCON TRACON Pharmaceuticals Inc 2021-07-26 602 1.49 897

Holding Weightings of Saundra L Pelletier


Saundra L Pelletier Form 4 Trading Tracker

According to the SEC Form 4 filings, Saundra L Pelletier has made a total of 9 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years, including 4 buys and 5 sells. The most-recent trade in Evofem Biosciences Inc is the acquisition of 141,000 shares on May 27, 2022, which cost Saundra L Pelletier around $49,350.

According to the SEC Form 4 filings, Saundra L Pelletier has made a total of 2 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 327 shares on July 26, 2021, which cost Saundra L Pelletier around $25,002.

Insider Trading History of Saundra L Pelletier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Saundra L Pelletier Trading Performance

GuruFocus tracks the stock performance after each of Saundra L Pelletier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saundra L Pelletier is 15.9%. GuruFocus also compares Saundra L Pelletier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saundra L Pelletier within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Saundra L Pelletier's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Saundra L Pelletier

Average Return

Average return per transaction

Outperforming Transactions

2 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 40.75
Relative Return to S&P 500(%) 39.41

Saundra L Pelletier Ownership Network

Ownership Network List of Saundra L Pelletier

No Data

Ownership Network Relation of Saundra L Pelletier


Saundra L Pelletier Owned Company Details

What does Evofem Biosciences Inc do?

Who are the key executives at Evofem Biosciences Inc?

Saundra L Pelletier is the director & Chief Executive Officer of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .

Evofem Biosciences Inc (EVFM) Insider Trades Summary

Over the past 18 months, Saundra L Pelletier made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .

In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.

Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evofem Biosciences Inc Insider Transactions

No Available Data

Saundra L Pelletier Mailing Address

Above is the net worth, insider trading, and ownership report for Saundra L Pelletier. You might contact Saundra L Pelletier via mailing address: C/o Evofem Biosciences, Inc., 12400 High Bluff Drive, Suite 600, San Diego Ca 92130.

Discussions on Saundra L Pelletier

No discussions yet.